World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
91
Citations
34130
World Ranking
11666
National Ranking
1108

Chris Robertson publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Chris Robertson sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 429 publications — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Chris Robertson D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Chris Robertson sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 91 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Chris Robertson is affiliated with the University of Strathclyde in the United Kingdom. Their research primarily focuses on the field of Medicine, with specific attention to subfields such as Infectious Diseases, Health, Epidemiology, Obstetrics and Gynecology, and Oncology. The volume of publications reflects a concentrated effort in these areas, particularly relating to infectious disease epidemiology and clinical research.

The scientist has contributed extensively to the understanding of SARS-CoV-2 and COVID-19, with over a hundred related publications. Their main topics of work include SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Vaccine Coverage and Hesitancy, COVID-19 and healthcare impacts, COVID-19 Impact on Reproduction, COVID-19 epidemiological studies, and Influenza Virus Research Studies.

Frequent co-authors include Aziz Sheikh, Colin R Simpson, Colin McCowan, Srinivasa Vittal Katikireddi, and Lewis Ritchie. This collaboration network highlights ongoing partnerships in epidemiological and clinical research projects.

Robertson's papers have often been published in notable venues including bioRxiv, The Lancet, SSRN Electronic Journal, BMJ Open, and Nature Communications. These journals are known for disseminating high-impact research, particularly in medical and epidemiological sciences.

Selected recent publications demonstrate the scientist's focus on COVID-19 vaccine effectiveness and risk assessments related to SARS-CoV-2:

  • Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study (2021, BMJ)
  • SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness (2021, The Lancet)
  • Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study (2021, The Lancet)
  • Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection (2021, Nature Medicine)
  • Risk of hospital admission with coronavirus disease 2019 in healthcare workers and their households: nationwide linkage cohort study (2020, BMJ)

Best Publications

  • A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer.

    Umberto Veronesi;Giovanni Paganelli;Giuseppe Viale;Alberto Luini

  • Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7).

    Raymond Rosen;Jens Altwein;Peter Boyle;Roger S Kirby

  • Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.

    James Lopez Bernal;James Lopez Bernal;James Lopez Bernal;Nicholas Andrews;Nicholas Andrews;Charlotte Gower;Chris Robertson

  • Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series.

    U Veronesi;G Paganelli;G Viale;V Galimberti

  • Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women

    U Veronesi;P Maisonneuve;A Costa;V Sacchini

  • SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness.

    Aziz Sheikh;Jim McMenamin;Bob Taylor;Chris Robertson

  • Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels

    M. Colleoni;A. Rocca;M. T. Sandri;L. Zorzino

  • Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study.

    Eleftheria Vasileiou;Colin R. Simpson;Colin R. Simpson;Ting Shi;Steven Kerr

  • Very young women (<35 years) with operable breast cancer: features of disease at presentation

    M. Colleoni;N. Rotmensz;C. Robertson;L. Orlando

  • Meta-analysis of studies on breast cancer risk and diet: the role of fruit and vegetable consumption and the intake of associated micronutrients.

    S. Gandini;H. Merzenich;C. Robertson;P. Boyle

  • Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria.

    Georg Bartsch;Wolfgang Horninger;Helmut Klocker;Andreas Reissigl

  • Statistical methods for the prospective detection of infectious disease outbreaks: a review

    Steffen Unkel;C. Paddy Farrington;Paul H. Garthwaite;Christopher Robertson

  • Depression and degree of acceptance of adjuvant cytotoxic drugs

    Marco Colleoni;Mario Mandala;Giulia Peruzzotti;Chris Robertson

  • Risk of hospital admission with coronavirus disease 2019 in healthcare workers and their households: nationwide linkage cohort study.

    Anoop Sv Shah;Anoop Sv Shah;Rachael Wood;Ciara Gribben;David Caldwell

  • Diabetes and breast cancer risk: a meta-analysis

    P. Boyle;M. Boniol;A. Koechlin;C. Robertson

  • Measuring the effect of enhanced cleaning in a UK hospital: a prospective cross-over study

    Stephanie J Dancer;Stephanie J Dancer;Liza F White;Jim Lamb;E Kirsty Girvan

  • The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study.

    P. Boyle;C. Robertson;C. Mazzetta;M. Keech

  • Intermittent androgen deprivation for locally advanced and metastatic prostate cancer: results from a randomised phase 3 study of the South European Uroncological Group.

    Fernando E.C. Calais da Silva;Aldo V. Bono;Peter Whelan;Maurizio Brausi

  • Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection.

    Martina Patone;Lahiru Handunnetthi;Defne Saatci;Jiafeng Pan

  • Finding a benchmark for monitoring hospital cleanliness

    D. Mulvey;P. Redding;Christopher Robertson;C. Woodall

Frequent Co-Authors

Peter Boyle
Peter Boyle University of Edinburgh
Aziz Sheikh
Aziz Sheikh University of Oxford
Bernardo Bonanni
Bernardo Bonanni European Institute of Oncology
Umberto Veronesi
Umberto Veronesi European Institute of Oncology
Richard Pebody
Richard Pebody Public Health England
Georg Bartsch
Georg Bartsch University of Innsbruck
Patrick Maisonneuve
Patrick Maisonneuve European Institute of Oncology
Joanna Ellis
Joanna Ellis Public Health England
Maria Zambon
Maria Zambon Public Health England

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring career options related to medicine can open doors beyond becoming a physician. Many students begin their healthcare journey through nursing. If affordability is your priority, researching the cheapest rn to bsn program options can help you complete your degree without excessive debt.

For those seeking advanced roles, non-nurses may consider direct entry msn programs for non-nurses online. These programs fast-track those with a bachelor’s in another field into the nursing profession.

If you’re worried about admissions requirements, the easiest nursing schools to get into may offer greater accessibility — perfect for career changers or those strengthening their academic profile.

Prefer an administrative or non-clinical role? Accredited programs in medical billing and coding are in high demand. Discover accredited medical billing and coding schools with financial aid to launch a stable healthcare career online. These pathways show that the medical field offers many accessible and flexible options for students with diverse interests and goals.

Best Scientists Citing Chris Robertson

Trending Scientists

Recently Published Articles